1. Mylan’s drug Fulphila represents the first biosimilar version of Amgen’s Neulasta, both of which boost white blood cell count to reduce infection risk in cancer patients undergoing chemotherapy.
2. Rituxan is the first treatment approved for moderate-to-severe pemphigus vulgaris, a rare autoimmune disease characterized by painful blistering on the skin and mucous membranes.
3. Mircera may now be used to treat chronic kidney disease-associated anemia in children.
More articles on supply chain:
How University of Washington Medical Center improved supply chain efficiency and saved $1M+
3 ways to understand healthcare supply chain in a changing market
Fitch: New drug approvals off pace from 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
